HAIKOU CITY, China, Nov. 17 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it will present at the Brean Murray, Carret & Co. 2009 China Growth Conference, to be held November 19-20, 2009 at the Millennium Broadway hotel in New York. Management is scheduled to present at 4:20 pm ET on Thursday, November 19, and meet with institutional investors throughout the event.
For further details, please contact your Brean Murray institutional sales representative.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
For more information, please contact: China Pharma Holdings, Inc. Tel: +86-898-6681-1730 Email: firstname.lastname@example.org ICR, Inc. Christine Duan Tel: +1-203-682-8200
SOURCE China Pharma Holdings, Inc.
|SOURCE China Pharma Holdings, Inc.|
Copyright©2009 PR Newswire.
All rights reserved